sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> antifungal treatment market

report

Antifungal Treatment Market, by Drugs Class (Azoles, Pyrimidines, Echinocandins, Polyenes, Allylamines, Others ), Therapeutic Indication (Systemic, Candidiasis, Coccidioidomycosis, Cryptococcosis), Pathogens (Candida, Aspergillus, Cryptococcus, Coccidioides Immitis, Zygomycetes, Trichophyton, Others), End-user (Hospitals & Clinics, Dermatology Clinics, Other) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC391 September 2017 100+ FREE 10% CUSTOMIZATION

Fungal infections like ringworm infection, athlete's foot, serious systemic infections, and others are rapidly spreading around the globe and no. of treatments available for treating these diseases. Growing prevalence of immunological disease as well as availability of huge range of products is driving the market growth of global market for antifungal treatment. Additionally, increasing awareness associated with the side effects of drugs as well as availability of latest drugs favoring the market growth of antifungal treatment. Aidding antifungal drugs in deterring wall development of fungal cell and disrupt their cell proliferation and cell membrane.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the antifungal treatment market. The scope of this report covers the antifungal treatment market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Globally, at the front of powerful demand in the antifungal treatment market is the growing knowledge of fungal infections and escalating infection instances on the account of infuriating unhygienic environment in the highly populated areas of the world. For example, systemic candidiasis is the most occuring systemic fungal infection projected to drive the growth during the forecast period.
  • The availability of several antifungal treatment in the global market for treating them and the increasing popularity of these drugs for certain infections has boosted the market growth of antifungal treatment.
  • The available antifungal therapies are drugs, ointments, powders, and pastes. Also, azoles antifungal drugs is holding dominant market share in the global market for antigfungal treatment due to increasing awareness about these drugs.

Regionally, the global antifungal treatment market segmented into Europe, North America, Asia-Pacific, and the Rest of the World. Among these, North America is leading the global market for antifungal treatment with dominant market share. Europe region was following North Americ region in the global antifungal treatment market owing to growing prevalence of fungal infections and antifungal biopharmaceuticals development that are unique. In the coming years, Asia Pacific region is projected to register considerable growth mainly in several developing economies. The growing per capita income along with increasing awareness of personal hygiene, and good access to faciltities of healthcare has fueled the growth of antifungal treatment market in these regions.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s antifungal treatment market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the antifungal treatment market by the following segments:

  • Antifungal Treatment Market, by Drugs Class
    • Azoles
    • Pyrimidines
    • Echinocandins
    • Polyenes
    • Allylamines
    • Others
  • Antifungal Treatment Market, by Therapeutic Indication
    • Systemic
    • Candidiasis
    • Coccidioidomycosis
    • Cryptococcosis
  • Antifungal Treatment Market, by Pathogen
    • Candida
    • Aspergillus
    • Cryptococcus
    • Coccidioides Immitis
    • Zygomycetes
    • Trichophyton
    • Others
  • Antifungal Treatment Market, by End-users
    • Hospitals & Clinics
    • Dermatology Clinics
    • Other

KEY MARKET PLAYERS

Key players in the antifungal treatment market include:

  • Pfizer, Inc.
  • Astellas
  • Novartis AG.
  • Sanofi
  • Merck & Co., Inc.
  • Bayer AG
  • Abbott

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • MIDDLE EAST & AFRICA
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa
  • LATIN AMERICA
    • Brazil
    • Rest of Latin America

TRENDING RELATED REPORT

Healthcare IT Market, by Type(Solution, Service) By Solution (Clinical Healthcare IT Solution, Non-Clinical Healthcare IT Solution, Healthcare Payer Solution), By Service (Integration and Implementation, Consulting, Outsourcing, Repair and Maintenance) By End-user (Diagnostic Centres, Hospitals, Nursing Home &Home Healthcare Service, Pharmacies, Ambulatory Care Centre), By Delivery System (On Premise, Cloud Based) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
  5. ANTIFUNGAL TREATMENT MARKET, BY DRUGS CLASS
    1. Segment Share
    2. By Drug Class
      1. Azoles
      2. Pyrimidines
      3. Echinocandins
      4. Polyenes
      5. Allylamines
      6. Others
  6. ANTIFUNGAL TREATMENT MARKET, BY THERAPEUTIC INDICATION
    1. Segment Share
    2. By Therapeutic Indication
      1. Systemic
      2. Candidiasis
      3. Coccidioidomycosis
      4. Cryptococcosis
  7. ANTIFUNGAL TREATMENT MARKET, BY PATHOGEN
    1. Segment Share
    2. By Pathogen
      1. Candida
      2. Aspergillus
      3. Cryptococcus
      4. Coccidioides Immitis
      5. Zygomycetes
      6. Trichophyton
      7. Others
  8. ANTIFUNGAL TREATMENT MARKET, BY END-USERS
    1. Segment Share
    2. By End-user
      1. Hospitals & Clinics
      2. Dermatology Clinics
      3. Other
  9. ANTIFUNGAL TREATMENT MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Pathogen
      5. By End-user
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Pathogen
      5. By End-user
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Pathogen
      5. By End-user
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Drug Class
      3. By Therapeutic Indication
      4. By Pathogen
      5. By End-user
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
  11. KEY MARKET PLAYERS
    1. Pfizer, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. Astellas
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Novartis AG.
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Sanofi
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Merck & Co., Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Bayer AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Abbott
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us